Janus Henderson Group PLC Sells 238,149 Shares of Progyny, Inc. (NASDAQ:PGNY)

Janus Henderson Group PLC lowered its holdings in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 32.7% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 489,377 shares of the company's stock after selling 238,149 shares during the period. Janus Henderson Group PLC owned about 0.57% of Progyny worth $8,202,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. International Assets Investment Management LLC raised its holdings in shares of Progyny by 1,576.0% during the 3rd quarter. International Assets Investment Management LLC now owns 2,565,118 shares of the company's stock worth $42,991,000 after buying an additional 2,412,068 shares in the last quarter. Pacer Advisors Inc. boosted its stake in shares of Progyny by 12,579.4% during the third quarter. Pacer Advisors Inc. now owns 2,492,642 shares of the company's stock valued at $41,777,000 after purchasing an additional 2,472,983 shares in the last quarter. Farallon Capital Management LLC grew its holdings in shares of Progyny by 120.8% during the second quarter. Farallon Capital Management LLC now owns 1,308,500 shares of the company's stock worth $37,436,000 after purchasing an additional 715,900 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Progyny by 24.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,281,928 shares of the company's stock valued at $36,676,000 after buying an additional 254,725 shares during the last quarter. Finally, Kornitzer Capital Management Inc. KS boosted its position in Progyny by 15.7% during the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 976,501 shares of the company's stock worth $16,366,000 after buying an additional 132,672 shares during the period. Institutional investors and hedge funds own 94.93% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on PGNY shares. Barclays dropped their price target on shares of Progyny from $30.00 to $17.00 and set an "overweight" rating for the company in a research note on Thursday, November 14th. JMP Securities downgraded Progyny from an "outperform" rating to a "market perform" rating in a report on Thursday, September 19th. Jefferies Financial Group decreased their price target on Progyny from $31.00 to $24.00 and set a "buy" rating for the company in a research note on Thursday, September 19th. Leerink Partners cut their price objective on Progyny from $25.00 to $21.00 and set a "market perform" rating on the stock in a research note on Thursday, September 19th. Finally, Bank of America decreased their target price on shares of Progyny from $22.00 to $21.00 and set a "buy" rating for the company in a research report on Wednesday, November 13th. Nine investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Progyny has an average rating of "Hold" and an average target price of $25.00.

Progyny Stock Up 7.3 %

NASDAQ:PGNY traded up $1.08 during trading hours on Monday, reaching $15.84. The company had a trading volume of 1,769,380 shares, compared to its average volume of 1,400,453. Progyny, Inc. has a twelve month low of $13.39 and a twelve month high of $42.08. The firm has a market cap of $1.35 billion, a price-to-earnings ratio of 27.31, a P/E/G ratio of 1.66 and a beta of 1.35. The business's 50-day simple moving average is $15.61 and its two-hundred day simple moving average is $21.63.

Progyny (NASDAQ:PGNY - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.26). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The firm had revenue of $286.63 million during the quarter, compared to the consensus estimate of $296.85 million. During the same period in the previous year, the firm earned $0.16 earnings per share. The business's quarterly revenue was up 2.0% on a year-over-year basis. As a group, equities analysts predict that Progyny, Inc. will post 0.59 earnings per share for the current year.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.